Stock Scorecard



Stock Summary for Sensus Healthcare Inc (SRTS) - $8.94 as of 11/20/2024 8:44:25 PM EST

Total Score

18 out of 30

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for SRTS

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for SRTS

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for SRTS

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for SRTS

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for SRTS (44 out of 90)

Stock Price Rating (Max of 10) 4
Historical Stock Price Rating (Max of 10) 3
Stock Price Trend (Max of 10) 10
Book Value (Max of 10) 2
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 2
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 6
Trading Volume (Max of 10) 5
Price to Earnings (Max of 10) 8

Latest News for for SRTS

Wall Street Analysts See a 39.66% Upside in Sensus Healthcare ( SRTS ) : Can the Stock Really Move This High? 11/18/2024 2:55:00 PM
REVISED - Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter 11/18/2024 1:32:00 AM
Sensus Healthcare, Inc. ( SRTS ) Surpasses Q3 Earnings and Revenue Estimates 11/14/2024 8:25:00 PM
Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter 11/14/2024 5:06:00 PM
Hyperfine, Inc. ( HYPR ) Reports Q3 Loss, Tops Revenue Estimates 11/12/2024 10:35:00 PM
Astrana Health, Inc. ( ASTH ) Meets Q3 Earnings Estimates 11/7/2024 11:30:00 PM
Sensus Healthcare to Host Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 14, 2024 - Sensus Healthcare ( NASDAQ:SRTS ) 10/31/2024 12:00:00 PM
Idexx Laboratories ( IDXX ) Q3 Earnings Surpass Estimates 10/31/2024 11:40:00 AM
Sensus Healthcare, Inc. ( SRTS ) Outperforms Broader Market: What You Need to Know 10/24/2024 10:15:00 PM
Sensus Healthcare, Inc. ( SRTS ) Ascends While Market Falls: Some Facts to Note 10/1/2024 10:15:00 PM

Financial Details for SRTS

Company Overview

Ticker SRTS
Company Name Sensus Healthcare Inc
Country USA
Description Sensus Healthcare, Inc. manufactures, distributes and markets superficial radiation therapy devices to healthcare providers worldwide. The company is headquartered in Boca Raton, Florida.
Sector Name LIFE SCIENCES
Industry Name SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Most Recent Quarter 9/30/2024
Next Earnings Date 2/6/2025

Stock Price History

Last Day Price 8.94
Price 4 Years Ago 3.86
Last Day Price Updated 11/20/2024 8:44:25 PM EST
Last Day Volume 459,455
Average Daily Volume 164,802
52-Week High 8.69
52-Week Low 2.05
Last Price to 52 Week Low 336.10%

Valuation Measures

Trailing PE 18.63
Industry PE 52.46
Sector PE 40.32
5-Year Average PE 24.96
Free Cash Flow Ratio 6.48
Industry Free Cash Flow Ratio 35.05
Sector Free Cash Flow Ratio 27.97
Current Ratio Most Recent Quarter 10.52
Total Cash Per Share 1.38
Book Value Per Share Most Recent Quarter 1.57
Price to Book Ratio 2.37
Industry Price to Book Ratio 5.44
Sector Price to Book Ratio 20.88
Price to Sales Ratio Twelve Trailing Months 3.44
Industry Price to Sales Ratio Twelve Trailing Months 13.48
Sector Price to Sales Ratio Twelve Trailing Months 7.11
Analyst Buy Ratings 1
Analyst Strong Buy Ratings 3

Share Statistics

Total Shares Outstanding 16,389,100
Market Capitalization 146,518,554
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 433.30%
Annual Earnings Growth -98.00%
Reported EPS 12 Trailing Months 0.41
Reported EPS Past Year 0.31
Reported EPS Prior Year 0.03
Net Income Twelve Trailing Months 9,311,000
Net Income Past Year 485,000
Net Income Prior Year 24,244,000
Quarterly Revenue Growth YOY 155.70%
5-Year Revenue Growth -1.58%
Operating Margin Twelve Trailing Months 0.41

Balance Sheet

Total Cash Most Recent Quarter 22,558,000
Total Cash Past Year 23,148,000
Total Cash Prior Year 25,520,000
Net Cash Position Most Recent Quarter 22,507,000
Net Cash Position Past Year 23,097,000
Long Term Debt Past Year 51,000
Long Term Debt Prior Year 51,000
Total Debt Most Recent Quarter 51,000
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 48,842,000
Total Stockholder Equity Prior Year 48,069,000
Total Stockholder Equity Most Recent Quarter 54,131,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 2,091,000
Free Cash Flow Per Share Twelve Trailing Months 0.13
Free Cash Flow Past Year -2,374,000
Free Cash Flow Prior Year -1,571,000

Options

Put/Call Ratio 3.82
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.16
MACD Signal 0.13
20-Day Bollinger Lower Band 5.41
20-Day Bollinger Middle Band 6.28
20-Day Bollinger Upper Band 7.16
Beta 1.04
RSI 56.47
50-Day SMA 4.79
150-Day SMA 6.30
200-Day SMA 5.79

System

Modified 11/19/2024 1:23:07 PM EST